Evidence map›Paper›PMID 33781249›Full record

ArticleBMC medicine2021

Dietary intake of trans fatty acids and breast cancer risk in 9 European countries.

Michèle Matta, Inge Huybrechts, Carine Biessy, Corinne Casagrande, Sahar Yammine, Agnès Fournier, Karina Standahl Olsen, Marco Lukic, Inger Torhild Gram, Eva Ardanaz and 28 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. [Ecological analysis of the association between dietary factors and thyroid carcinoma incidence based on GBD 2021 data].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Plasma metabolomics profiles and breast cancer risk.Breast cancer research : BCR · 2024
    Article
  14. Article
  15. CD36: The Bridge between Lipids and Tumors.Molecules (Basel, Switzerland) · 2024
    Review
  16. Frontiers in nutrition · 2024
    Review
  17. Dietary fat and lipid metabolism in the tumor microenvironment.Biochimica et biophysica acta. Reviews on cancer · 2023
    Review
  18. Validity and reproducibility of the intake ofThe British journal of nutrition · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 19 institutions in 9 countries.

Michèle MattaNutrition and Metabolism Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France.
Inge HuybrechtsNutrition and Metabolism Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France.
Carine BiessyNutrition and Metabolism Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France.
Corinne CasagrandeNutrition and Metabolism Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France.
Sahar YammineNutrition and Metabolism Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France.
Agnès FournierCESP "Health Across Generations", INSERM, Univ Paris-Sud, UVSQ, Univ Paris-Saclay, Villejuif, France.
Karina Standahl OlsenDepartment of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Marco LukicDepartment of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Inger Torhild GramDepartment of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Eva ArdanazNavarra Public Health Institute, Pamplona, Spain.
Maria-José SánchezCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Laure DossusNutrition and Metabolism Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France.
Renée T FortnerDivision of Cancer Epidemiology, German Cancer Research Centre (DFKZ), Heidelberg, Germany.
Bernard SrourDivision of Cancer Epidemiology, German Cancer Research Centre (DFKZ), Heidelberg, Germany.
Franziska JannaschDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Pilar AmianoCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Antonio AgudoUnit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
Sandra Colorado-YoharCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
J Ramón QuirósPublic Health Directorate, Asturias, Spain.
Rosario TuminoCancer Registry and Histopathology Department, Provincial Health Authority (ASP 7), Ragusa, Italy.
Salvatore PanicoDipartimento Di Medicina Clinica e Chirurgia, Federici II University, Naples, Italy.
Giovanna MasalaCancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.
Valeria PalaEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, di Milano Via Venezian, 1, 20133, Milan, Italy.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Via Santena 7, 10126, Turin, Italy.
Anne TjønnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Anja OlsenDanish Cancer Society Research Center, Copenhagen, Denmark.
Christina C DahmDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Ann H RosendahlClinical Sciences Lund, Oncology, Lund University and Skåne University Hospital, Lund, Sweden.
Signe BorgquistClinical Sciences Lund, Oncology, Lund University and Skåne University Hospital, Lund, Sweden.
Maria WennbergDepartment of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University, Umeå, Sweden.
Alicia K HeathDepartment of Epidemiology and Biostatistics, Imperial College London, London, UK.
Dagfinn AuneDepartment of Epidemiology and Biostatistics, Imperial College London, London, UK.
Julie SchmidtCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Elisabete WeiderpassOffice of the Director, International Agency for Research on Cancer, Lyon, France.
Veronique ChajesNutrition and Metabolism Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France.
Marc J GunterNutrition and Metabolism Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France.
Neil MurphyNutrition and Metabolism Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France. murphyn@iarc.fr.
Centre international de recherche sur le cancer · FRUiT The Arctic University of Norway · NOCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESDanish Cancer Society · DKGerman Cancer Research Center · DEImperial College London · GBLund University · SEAarhus University · DKDeutsches Diabetes-Zentrum e.V. · DEFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Institute of Human Nutrition · DEGobierno del Principado de Asturias · ESInserm · FRInstitut d'Investigació Biomédica de Bellvitge · ESInstituto Murciano de Investigación Biosanitaria · ESUmeå University · SEUniversidad de Granada · ESUniversity of Oxford · GB

Funding

Cancer Research UKMedical Research Council MR/M012190/1World Health Organization 001
6 · The paper itself

Abstract

backgroundTrans fatty acids (TFAs) have been hypothesised to influence breast cancer risk. However, relatively few prospective studies have examined this relationship, and well-powered analyses according to hormone receptor-defined molecular subtypes, menopausal status, and body size have rarely been conducted.

methodsIn the European Prospective Investigation into Cancer and Nutrition (EPIC), we investigated the associations between dietary intakes of TFAs (industrial trans fatty acids [ITFAs] and ruminant trans fatty acids [RTFAs]) and breast cancer risk among 318,607 women. Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models, adjusted for other breast cancer risk factors.

resultsAfter a median follow-up of 8.1 years, 13,241 breast cancer cases occurred. In the multivariable-adjusted model, higher total ITFA intake was associated with elevated breast cancer risk (HR for highest vs lowest quintile, 1.14, 95% CI 1.06-1.23; P trend = 0.001). A similar positive association was found between intake of elaidic acid, the predominant ITFA, and breast cancer risk (HR for highest vs lowest quintile, 1.14, 95% CI 1.06-1.23; P trend = 0.001). Intake of total RTFAs was also associated with higher breast cancer risk (HR for highest vs lowest quintile, 1.09, 95% CI 1.01-1.17; P trend = 0.015). For individual RTFAs, we found positive associations with breast cancer risk for dietary intakes of two strongly correlated fatty acids (Spearman correlation r = 0.77), conjugated linoleic acid (HR for highest vs lowest quintile, 1.11, 95% CI 1.03-1.20; P trend = 0.001) and palmitelaidic acid (HR for highest vs lowest quintile, 1.08, 95% CI 1.01-1.16; P trend = 0.028). Similar associations were found for total ITFAs and RTFAs with breast cancer risk according to menopausal status, body mass index, and breast cancer subtypes.

conclusionsThese results support the hypothesis that higher dietary intakes of ITFAs, in particular elaidic acid, are associated with elevated breast cancer risk. Due to the high correlation between conjugated linoleic acid and palmitelaidic acid, we were unable to disentangle the positive associations found for these fatty acids with breast cancer risk. Further mechanistic studies are needed to identify biological pathways that may underlie these associations.

Indexed as

Breast NeoplasmsTrans Fatty AcidsDietEatingFemaleHumansProportional Hazards ModelsProspective StudiesRiskRisk FactorsTrans Fatty AcidsBreast cancerDietIndustrial trans fatty acidsRuminant trans fatty acids

Identifiers

PMID33781249
PMCPMC8008592
OpenAlexW3145548293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.